

LONDON, Dec 19 (Reuters) - Shares in Vernalis fell sharply on Friday as Swiss drugmaker Novartis stopped development work on a drug licensed from the ...


TSB Banking: Shore Capital reiterates buy with a target price for 325p. Vernalis: Canaccord Genuity ups target to 66p from 56p and reiterates buy. Ag...